Trusted By
9,000+ Patients Globally
Experience of
30+ Years
7000+ Surgeries
Completed

Veno Arterial & Venous ECMO Therapy Mumbai, India

Veno Arterial & Venous ECMO Therapy

Dr Vishal Khullar, a leading provider of Veno Arterial & Veno Venous ECMO therapy in Mumbai, offers unparalleled expertise and compassionate care, ensuring you receive the best treatment. Let us take a look at how these two therapies offer life-saving support for patients with severe heart and lung conditions:

  • Veno Arterial Treatment In Mumbai, India: Veno-arterial ECMO therapy supports both heart and lung functioning, relieving the pressure on the organs and allowing them to heal. In Veno Arterial ECMO Therapy, the machine is connected to the body through two cannulae, one inserted in the large vein and another in a large artery.
  • Veno Venous ECMO Treatment In Mumbai, India: Veno-venous ECMO therapy supports only lung function, making it possible for the lungs to recover. In venovenous ECMO therapy, the machine is connected to the body through two cannulae, one large vein in the neck and second cannulae goes in the groin.

Both of these ECMO therapy methods can be used to improve the health of patients with end-stage heart and lung failure.
 
So, if you or your loved ones are in need of either Veno Arterial or Veno Venous ECMO Treatment In India, you should contact us and we’ll ensure that you have the best possible outcomes.

Advanced Veno-Arterial and Veno-Venous ECMO Therapy

Life-Saving Solutions for Critical Heart and Lung Conditions

Request an Appointment

Frequently Asked Questions

1. What are the major advantages of Veno-venous ECMO & Veno-arterial ECMO?

Veno-venous ECMO (VV ECMO), a type of extracorporeal membrane oxygenation, provides respiratory support, ensuring that your lungs can rest properly and recover quicker.  Veno-arterial ECMO (VA ECMO) offers respiratory and cardiac support, ensuring you receive complete circulatory support while maintaining organ perfusion even when the heart is failing. Both VV ECMO and VA ECMO can be lifesaving interventions for patients with severe respiratory or cardiac failure. They have also shown improved survival rates.

2. What are the indications of Veno-venous ECMO?

Veno-venous ECMO is indicated in patients facing severe respiratory failure caused by conditions such as pneumonia, acute respiratory distress syndrome, or lung transplant complications and conventional treatments such as mechanical ventilation have failed to provide adequate oxygen to the patient veno-venous ECMO is indicated.

3. Does Veno-venous ECMO support heart?

Veno-venous ECMO does not provide direct support for the heart, it is used for respiratory support by providing oxygenation and CO2 removal to allow the lungs to rest and recover. While Veno-venous ECMO doesn’t provide heart support, Veno-arterial ECMO offers cardiac support in people experiencing heart failure.

4. How long can you use Veno-venous ECMO?

The duration for which a person needs Veno-venous ECMO varies for each individual based on their condition and response to the treatment. Some patients come off ECMO after less than 7 days whereas others might need to be on ECMO for 2-3 months. In case the patient is on VA ECMO, on an average a patient requires 5-10 days for proper recovery,  whereas with VV ECMO recovery could take 3-4 weeks.

5. Is Veno-venous ECMO better than Veno-arterial ECMO?

The comparison between Veno-venous ECMO and Veno-arterial ECMO tells us that one is not better than the other. They are both used for different purposes and the decision to choose the correct option depends on the patient’s condition and the doctor’s recommendation. However, you should note that Veno-venous ECMO has fewer complications than Veno-arterial ECMO. This could be because Veno-arterial ECMO has to provide support for respiratory and cardiac functions.

6. What is the survival rate of Veno-arterial ECMO?

Depending on factors such as the underlying medical condition, severity of the organ failure, and the patient’s overall health status the survival rate may vary. Typically the survival rate ranges from 30% to 70%.